In the first step of flavivirus replication, the 5′-end of viral genomic RNA is thought to interact with the 3′-end of the genomic RNA at the complimentary sequences (CSs) located at both ends of the genomic RNA. However, there is little evidence of direct interaction between the two ends of the viral genomic RNA in virus-replicating cells. Herein, we show that viral small negative-strand RNA species, composed of two ends corresponding to the upstream of the 5′-end CS and the downstream of the 3′-end CS of viral genomic RNA, were synthesized during viral replication. We hypothesized that the viral small negative-sense RNAs were synthesized during viral negative-sense RNA synthesis through the template-jumping of viral RNA-dependent RNA polymerase from the 3′-end to the 5′-end of viral genomic RNA used as a template. Our present results strongly indicate that the two ends of viral genomic RNA associate with each other during viral replication.
Introduction
West Nile virus (WNV) causes the mosquito-borne diseases, West Nile (WN) fever and WN encephalitis, in a variety of animals including humans and horses. WNV belongs to the family Flaviviridae and has a positive-sense, single-strand RNA genome. Most members of the virus family Flaviviridae, including WNV, yellow fever virus, Japanese encephalitis virus (JEV), and tick-borne encephalitis virus, cause arthropod-borne encephalitis (van Regenmortel et al., 2000) . After flavivirus attachment to the cell surface receptors, the virus internalizes and penetrates into cells using a low pH-dependent endocytic pathway (Chu and Ng, 2004; Heinz and Allison, 2003; Lindenbach and Rice, 2001) . In the flavivirus-infected cells, the viral polyprotein is first translated, processed by cellular and/or viral proteases, and then viral proteins are maturated. Subsequently, the viral replication complex (RC) is formed and is associated with the endoplasmic reticular (ER) or Golgi membranes (Grun and Brinton, 1988) . The molecular architecture of the initial RC is thought to consist of a number of viral nonstructural (NS) proteins, NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5; cellular proteins, p108, p105, p84, p60, p50, and p42; elongation factor 1α, Mov34, TIA-1, and TIAR Brinton, 1995, 1997; Li et al., 2002; Shi et al., 1996b; Ta and Vrati, 2000; Westaway et al., 1997) ; and also viral RNA. The viral negative-sense, genome-sized RNA is transcribed from the viral positive-sense genomic RNA, of approximately ∼ 11 kilo bases (kb) in size in the RC. Then, positive-sense viral genomic RNA is transcribed using the negative-sense, genome-sized RNA as its template.
The complimentary sequences (CSs) of WNV are positioned at both ends of the viral genomic RNA; the 3′-CS corresponding to positions 10,925 to 10,932 and the 5′-CS whose sequence is complementary to the 3′-CS, corresponding to Available online at www.sciencedirect.com Virology 371 (2008) 130 -138 www.elsevier.com/locate/yviro positions 137 to 144 (Hahn et al., 1987; Khromykh et al., 2001; Westaway et al., 2003) . This, therefore, implies that the genomic RNA of WNV forms a cyclized-panhandle structure. Furthermore, putative pseudoknot (PK) structures have been predicted at the 5′-and the 3′-end regions of the genomic positive-as well as the negative-sense RNAs. Ultraviolet crosslinking and site-directed mutagenetic studies of the CSs have suggested the importance of cyclization of the genomic RNA for negative-sense RNA synthesis in cells infected with flaviviruses, Dengue virus (DENV)-2 (You et al., 2001) , and Kunjin virus (KUNV) (Khromykh et al., 2001; Westaway et al., 2003) . Lo et al. precisely characterized the interaction between the 5′-and the 3′-CS during viral RNA replication using WNV replicons (Lo et al., 2003) . Recently, an electromicroscopic study by Filomatori et al. showed that DENV RNA cyclizes during the replication cycle (Filomatori et al., 2006) and more recently, the viral NS5, which is thought to be a viral RNAdependent RNA polymerase (RdRp), was found to bind to the 5′-terminal 3-4 nucleotides (nt) of the WNV genomic RNA (Dong et al., 2007) . These reports have provided strong evidence for the interaction between the 5′-and the 3′-ends of viral genomic RNA. In addition to viral genomic RNA, other species of viral subgenomic-sized RNAs have also been identified (Naeve and Trent, 1978; Takeda et al., 1978; Wengler et al., 1978) . However, the structures of these RNAs have not yet been clarified. Recently, Lin et al. showed that small viral RNAs are produced during the replication of JEV and characterized the structure of the small viral RNAs of JEV in detail (Lin et al., 2004) . Surprisingly, the viral small RNAs are comprised of only the positive-sense, 3′-end sequence of viral genomic RNA and are approximately ∼600 nt in size. Although Lin et al. suggested that the small viral RNAs regulated viral replication and persistency in the flavivirus-infected cells (Lin et al., 2004) , further evidence is required to prove this hypothesis. Such viral small RNAs are also produced in the Eg101 strain of WNV (WNV-Eg101)-infected cells (Scherbik et al., 2006) .
Herein, we show that viral small RNAs with sizes between 300 to 600 nt were also produced in WNV-infected cells. We also characterize the small RNA species of WNV and discuss how and why they were synthesized in viral replicating cells.
Results

Synthesis of WNV small RNA in viral infected cells
To examine the replication of WNV RNA in virus-infected cells, we extracted total cellular RNAs from Vero E6 cells infected with the WNV-Eg101 (Smithburn et al., 1940) , FCG (WNV-FCG, Castle et al., 1985) , or g2266 strains of WNV (WNV-g2266, Lanciotti et al., 1999) and performed Northern blot analysis using viral 3′-end specific probes labeled with digoxigenin (DIG). As shown by other researchers (Lin et al., 2004; Naeve and Trent, 1978; Scherbik et al., 2006) , we detected not only viral genome-sized RNA, but also ∼500-nt-sized RNA species in the WNV-Eg101 (Fig. 1, lane 5) , WNV-FCG, and WNV-g2266-infected cells (data not shown). Additionally, our results showed that the viral small RNAs, which were detected in WNV-infected cells, were not packaged into virus particles (Fig. 1, lane 6 and Fig. 2B, lane 2) . In this study, we chose WNV-Eg101 as a model virus to characterize the viral small RNAs.
Structural characterization of the WNV small RNAs
To characterize the viral small RNAs, we performed Northern blot analysis using the 5′-and the 3′-end probes for the detection of the 5′ and the 3′ regions of the viral RNA, respectively. Our results showed that the majority of the WNV small RNAs had the 3′-end sequence ( Fig. 1 lane 5) but not the 5′-end sequence of WNV genome-sized RNA (Fig. 1 , lanes 2). We hypothesized that WNV small RNAs were composed of at least two types of RNA species; one containing only the 3′-end sequence of viral positive-sense RNA and the other a viral defective interfering (DI) RNA, which contained the sequences of both ends of viral genomic RNA. The majority of viral small RNAs were thought to be the former, which could be detected by Northern blot analysis using the 3′-end probe, but not the 5′-end probe (Fig. 1) .
In this paper, we examined the possibility that a minor population of WNV small RNAs were viral replicating DI RNAs. If this were the case, we could amplify the viral small RNAs by using the 5′-and the 3′-end primers for WNVas both ends of viral genomic RNA should be responsible for viral RNA replication. The reverse transcription (RT) reaction was carried out using the total RNA extracted from Vero E6 cells infected with WNV as a template and a random hexamer as a primer. Then, the cDNA containing the 5′-and the 3′-end sequences of WNV genomic RNA was amplified by polymerase chain reaction (PCR) using oligos #1 and #2 corresponding to the 5′-end and the 3′-end sequences, respectively (Table 1) . As a result, ∼500-nt RNA sequences containing the 5′-and the 3′-end regions of WNV were 4) , from Vero E6 cells infected with WNV at 48 hours post infection (h.p.i.) (lanes 2 and 5), and from the culture medium of Vero E6 cells infected with WNV (lanes 3 and 6). Two micrograms of each RNA sample was run on 1% formaldehyde-denatured agarose gel and blotted onto nylon membranes. Viral specific RNAs on the membrane were hybridized with the 5′-end (lanes 1 to 3) or the 3′-end probes labeled with DIG (lanes 4 to 6). DIG on the membrane was then detected with a DIG-specific antibody as described in Materials and methods. The arrowhead and the arrow indicate the genomic RNA and the small RNA of WNV, respectively. amplified ( Fig. 2A , lane 2). However, we could not amplify the viral genomic RNA or the viral small RNAs using purified virion RNA as a template and the same primer set for RT-PCR (Fig. 2B , lane 2). This result eliminates the possibility that the viral small RNAs are synthesized during their cDNA synthesis. The PCR products of ∼500 base pair (bp) in size were then ligated into the pCRBlunt-II plasmid. We obtained nine independent clones (pCRB-II sRNAs clones #1 to #12) from a single PCR product. The inserted PCR products of the pCRBlunt-II plasmids were confirmed by PCR using oligos #1 and #2 (Fig. 2C ). The sequences of the inserted cDNAs were determined by cycle sequencing and are schematically shown in Fig. 2D . These cDNAs contained both end sequences of the viral genomic RNAs, including the viral CSs located at each end, except for clone #9, which had a truncated 6-nt sequence, UCAAUA, in place of the 8nt sequence, UCAAUAUG, of the 5′-end CS.
To examine the polarity of the viral small RNAs containing the 5′-and the 3′-end regions of viral genomic RNA, we performed strand-specific RT-PCRs. First, we evaluated the ability of our RT-PCR protocol to specifically amplify the positive-or the negativesense RNA. Positive-(+RNA) and negative-sense (−RNA) artificial RNAs containing the Aequorea coerulescens green fluorescent protein (AcGFP) gene sequence flanked by the 5′-and the 3′-end sequences of WNV were synthesized in vitro (Fig. 3A) . These RNAs were mixed with Vero E6 cell lysate and extracted from the mixture as described in Materials and methods. Subsequently, the strand-specific RT-PCR was carried out using these RNAs as templates. Firstly, we attempted the amplification of the +RNA using oligo #2 as the RT primer, and then the synthesized cDNA was amplified using oligos #1 and #2 as PCR primers ( Fig. 3B and 3C ). We could specifically amplify the +RNA (Fig. 3C, lane 1) , but not the −RNA (Fig. 3C, lane 3) . Next, we performed a similar experiment to amplify the −RNA using oligo #1 as the RT primer and oligos #1 and #2 as PCR primers ( Fig. 3B and C) . Similarly, we could amplify the −RNA (Fig. 3C, lane 4) , but not the +RNA (Fig. 3C, lane 2) . On the basis of these results, we concluded that our strand-specific RT-PCR worked sufficiently well for our research. Next, we tried to amplify the sequence of the viral small RNAs encoding both sequences of the 5′-and the 3′-end by our strand-specific RT-PCR using the RNA extracted from virus-infected cells (Fig. 3D) . Surprisingly, we could amplify only the negative-sense RNAs (Fig. 3D, lane 1) , but not the positive-sense RNAs (Fig. 3D , lane 3). We then confirmed this result by nested RT-PCR using oligos #3 and #4 as PCR primers (Fig. 3B ). Again, we could only amplify the negative- (Fig. 3D, lane 2) , but not the positive-sense RNAs (Fig. 3D, lane 4) .
The synthetic ratio of viral negative-sense small RNAs during viral negative-sense RNA synthesis
To estimate the ratio of the viral negative-sense small RNA synthesis during viral negative-sense RNA synthesis, we performed highly sensitive Northern blot analysis using a DIGlabeled, sense-directed RNA (sense-Ribo)-probe. To prepare the sense-Ribo-probe, we amplified the sequence of sRNA#7 using pCRB-II sRNA#7 as a template and oligo #9 and #5 containing an SP6 RNA polymerase promoter sequence as PCR primers. In vitro transcription was performed using SP6 polymerase, and the RNAs were labeled with DIG during in vitro transcription. Firstly, we confirmed the specificity of the polarity of the synthesized Ribo-probe. The negative-sense sRNA#7 RNA and positivesense WNV RNA were run on a denatured gel, blotted onto a nylon membrane, and probed with the sense-Ribo-probe. Results showed that our sense-Ribo-probe specifically recognized the negative-sense sRNA#7 RNA (Fig. 4A, lane 1) , but not the positive-sense WNV-RNA (Fig. 4A, lane 2) , confirming the effectiveness of the strand-specific Northern blot analysis. We then tried to detect the viral negative-sense, genome-sized RNA and the viral negative-sense small RNAs in virus-replicating cells. We successfully detected the RNAs using the sense-Ribo-probe and estimated the ratio of viral negative-sense small RNAs to viral negative-sense, genome-sized RNAs to be 0.53, as shown in Fig. 4A , lane 3. Additionally, we prepared an antisense-directed RNA-probe (antisense-Ribo-probe) to detect viral positive-sense RNAs. The membrane, which was used in the previous experiment, was de-probed and then re-probed with the antisense-Ribo-probe. We successfully detected viral positive-sense RNAs (Fig. 4B, lane 2) , but not the in vitro transcribed viral negative-sense RNA (Fig. 4B, lane1 ), again confirming the effectiveness of our strand-specific Northern blot analysis in detecting viral positive-sense RNAs in this experiment. Reprobing of the membrane was performed with the antisense-Riboprobe. We detected the positive-sense genome-sized and small RNAs in the WNV-infected cells (Fig. 4B, lane 3 ) and the ratio of these RNAs was 0.85, as shown in Fig. 4B .
Viral negative-sense small RNAs in WNV-NY and JEV-JaGAr 01 replicating cells
We also examined the presence of viral negative-sense small RNAs in WNV strain NY (WNV-NY)-, and other flavivirus, JEV strain JaGAr 01 (JEV-JaGAr 01)-replicating cells. Fig. 5 clearly shows that viral small RNA species of this kind were synthesized in the WNV-NY-and JEV-JaGAr 01-infected cells (Fig. 5, lanes 2 and 4, respectively) .
Discussion
In this paper, we have shown that there were at least two viral small RNA species in the WNV-replicating cells. Although structural characterization of the viral small RNAs has not yet been performed precisely, Takegami et al. have reported that viral small RNAs are produced in flavivirus-infected cells (Takegami and Hotta, 1990) . Recently, Lin et al. reported that the viral small RNAs are composed from just the 3′-end sequence of the genomic RNA of JEV with a size of 521 to 523 nt (Lin et al., 2004) . One of the viral small RNA species of WNV, which was identified by Scherbik et al. (2006) , has a similar RNA structure to that reported previously for JEV small RNA (Lin et al., 2004) . This type of viral small RNA contained just the 3′-end sequence of the viral positive-sense genomic RNA (Lin et al., 2004) . As the majority of the viral small RNA species were of this kind, they could be detected in the WNVreplicating cells by standard Northern blot analysis using a double-stranded cDNA probe labeled with DIG (Fig. 1) . The other species of viral small RNA identified in the WNV-infected cells by RT-PCR was composed of negative-sense RNAs including both the 5′-and the 3′-end sequences of negativesense, genome-sized RNA. Although it may be argued that these small RNAs are artificial products produced during the detection steps, especially during the cDNA synthesis step, using WNV genomic RNA as a template, it should be noted that we were unable to amplify the small-sized viral RNA species using purified virion RNAs (Fig. 2B, lane 2) . Furthermore, we also detected the viral negative-sense small RNAs in WNV-NYand JEV-JaGAr 01-replicating cells (Fig. 5) . These results provide convincing evidence for the presence of the viral negative-sense small RNAs in flavivirus-replicating cells generally. Additionally, we were unable to detect positivesense small RNAs containing the complimentary sequences of the negative-sense small RNA (Fig. 3D, lanes 3 and 4) . Therefore, as these RNAs do not act as templates for replication, this type of small RNAs is thought not to be a viral DI RNA. Fig. 6A shows the predicted interaction sequences (boxed sequences) of the 5′-and the 3′-end regions of WNV genomic RNA and the predicted tertiary interactions at each sequence of both ends of the genomic RNA (Khromykh et al., 2001; Shi et al., 1996a,b) . The CSs at each end of WNV RNA (the 5′-CS Fig. 3 . Polarity of the viral small RNAs containing the 5′-and the 3′-end sequences of the viral genome-sized RNA. To examine the effectiveness of our strand-specific RT-PCR in this experiment, positive-(+RNA) and negativestrand (-RNA) RNAs were synthesized by SP6 RNA polymerase using pCRB-5′ WNV/AcGFP/3′WNV (A-A) or pCRB-3′WNV/AcGFP/5′WNV (A-B) as templates for in vitro transcription, respectively. The SP6 RNA polymerase promoter sequence is shown as open triangles. The 5′-, the 3′-ends of the WNV genome sequence, and the sequence of AcGFP gene are also shown schematically. (B) Oligos used in this experiment are shown schematically. Their directions are indicated as arrows and their binding sites are plotted on the baseline of WNV genome. (C) In vitro-transcribed +RNA and − RNA were mixed with Vero E6 cell lysate, and again extracted. We were able to amplify the positive-sense RNAs using oligo #2 as the RT primer (lane 1), but not using #1 (lane 2). In contrast, the negative-sense RNAs were amplified using oligo #1 as the RT primer (lane 4), but not #2 (lane 3). The arrow and the arrowhead indicate the amplified full-length cDNA of 5′WNV/AcGFP/3′WNV or 3′WNV/AcGFP/ 5′WNV RNA, and the location of ∼ 500 bp-sized DNA, respectively. (D) To confirm the polarity of the viral small RNAs, we performed strand-specific RT-PCR (lanes 1 and 3) and strand-specific nested RT-PCR (lanes 2 and 4) using the primers shown in panel B. +, lanes 1 and 3) and negative-sense, small RNAs (as shown by −, lanes 2 and 4) were amplified by strand-specific RT-PCRs as described in the text. M: 100-bp DNA ladder marker. and the 3′-CS), the sequences of which are complementary, are thought to interact with each other for cyclization of viral genomic RNA during the viral replication cycle (Hahn et al., 1987; Khromykh et al., 2001; Westaway et al., 2003) . PK structures at the 3′-end region, PK1, PK2, and PK3, are thought to undergo tertiary interactions with PK1′, PK2′, and PK3′, respectively (Brinton, 2002) . We plotted the sequence positions at which the 5′-end sequence fused with the 3′-end sequence of the genomic RNA within the viral negative-sense small RNAs as shown in Fig. 6B . All of the negative-sense viral small RNAs contained the complementary sequence of the 5′-end sequence upstream of the 5′-CS of viral genomic RNA and the complementary sequence of the 3′-end sequence downstream of the 3′-CS of viral genomic RNA. It is worthy of note that the fusion sites of the 5′-end regions of all negative-sense small RNAs were located at sites between PK3 and PK2′ (Fig. 6B) . These results suggest that the cis-or trans-template-jumping of viral RdRp from the 3′-to the 5′-end of viral genomic RNA occurred at a site very close to the CSs during viral negativesense RNA synthesis. Our proposed model of the viral RdRp template-jumping during viral negative-sense RNA synthesis is shown schematically in Fig. 7 . According to our model, viral RdRp generally synthesizes a viral negative-sense, genomesized RNA using viral positive-sense, genome-sized RNA as a template (Fig. 7B) . However, the viral RdRp might produce the negative-sense small RNA accidentally through the templatejumping mechanism of viral RdRp (Fig. 7C ). Our present results suggest that the 5′-end of viral genomic RNA associates with the 3′-end of viral genomic RNA during the viral replication cycle in vivo. Thus, our results support the hypothesized of viral genome cyclization mechanism during viral replication reported by other researches (Filomatori et al., 2006; Hahn et al., 1987; Khromykh et al., 2001; Westaway et al., 2003; Lo et al., 2003; Dong et al., 2007) . The ratio of the amount of the negative-sense small RNAs to that of the negative-sense genome-sized RNAs, which might correspond to the incidence of template-jumping mutations of WNV RdRp, was surprisingly high at 0.53 (Fig. 4B) . It might be possible that viral negative-sense RNAs acts an important role for viral replication. However, we are unable to clarify the mechanism underlying this phenomenon in this time.
A possible mechanism for the generation of the positivesense viral small RNAs reported by Lin et al. in JEV (Lin et al., 2004) and Scherbic et al. in WNV (Scherbik et al., 2006) is that the positive-sense viral small RNAs are transcribed from degraded genomes or from the negative-sense small RNAs as templates during viral replication. Alternatively, the positivesense small RNAs might be degraded RNAs of viral genomic RNAs. As the sequence of the viral positive-sense small RNAs was predicted to form secondary or tertiary structures, this highly structured region might be stabilized by viral or hostderived proteins against digestion by RNases, except RNaseL (Scherbik et al., 2006) .
Unfortunately, the biological significance of the role of positive-and negative-sense viral small RNAs in the flavivirus replicating cycle remains unclear. However, recently, many noncording small RNAs, such as micro RNAs, have been shown to modulate cellular functions, cell proliferation and cell death (Brennecke et al., 2003) , cell differentiation (Chen, 2004 ), brain development (Krichevsky et al., 2003) , and viral infection (Lecellier et al., 2005; Pfeffer et al., 2004) . Lin et al. suggested that the viral small RNAs regulate viral replication and persistence in the host cells (Lin et al., 2004) like the DI RNA of many viruses. The DI RNA of flaviviruses is thought to regulate viral replication and their persistence in the cells infected with flaviviruses (Brinton, 1981; Brinton and Fernandez, 1983; Debnath et al., 1991; Schmaljohn and Blair, 1977; Fig. 6 . Predicted RNA structures of the 5′-and the 3′-ends regions of the positive-sense, genomic RNA and the fusion sites between the 5′-and the 3′-end sequences within the viral small RNAs. (A) We predicted the formation of one conserved pseudoknot (PK) structure at the 5′-end and three PKs (PK1, PK2 and PK3) at 3′-end region. The predicted tertiary interaction sites are shown as PK1', PK2' and PK3', respectively. The predicted tertiary interactions between PK1 and PK1', PK2 and PK2′, and PK3 and PK3′ are shown by dotted lines. The conserved 5′-and the 3′-CSs are shown as solid boxes on a modification of Brinton's figure (Brinton, 2002) . (B) The fusion sites between the 5′-and the 3′end sequences on the sequence of WNV genomic RNA corresponding to the negative-sense viral small RNAs are plotted by their cloned numbers. Fig. 7 . Proposed schematic model of the synthesis of viral negative-sense small RNAs in the WNV replication cycle. After viral penetration into the cells, viral RC could be formed by RdRp, other viral replicating proteins, some cellular proteins responsible for viral replication, and viral positive-sense genomic RNA associated with the replication site between the ER and the Golgi complex (A). Subsequently, the negative-sense genome-sized RNA was synthesized from the positive-sense genomic RNA as a template (B). It is possible that, viral RdRp accidentally jumps from a site very close to the 3′-CS of viral genomic RNA to the 5′-CS during viral negative-sense RNA synthesis. As a result, viral negativestrand small RNAs are synthesized during viral replication (C). CSs are shown as crossed-boxes. Positive-and negative-sense RNAs are marked as (+) and (−), respectively. The synthetic direction of negative-sense RNA is indicated by the arrows. Urosevic et al., 1997) . We are also interested in the possibility that the role of the small RNA species of WNV is to regulate not only cellular functions but also viral replication. We are now preparing an experiment to clarify the biological roles of such viral small RNA species in flavivirus-replicating cells.
Materials and methods
Viruses and cells
The Eg101 strain of WNV (GenBank accession no. AF260968) was used throughout in this study. The FCG (M12294), G2266 (AF196525), and NY strains of WNV (AF260967) and the JaGAr 01 strain of JEV (AF069076) were also used in some of our experiments. The viruses were propagated in Vero E6 cells and titrated by plaque assay. Vero E6 cells were grown in Dulbecco's modified Eagle′s medium supplemented with 10% fetal calf serum.
RNA extraction and Northern blot analysis
Vero E6 cells were infected with WNV at a multiplicity of infection (m.o.i.) of 10. Forty-eight hours post infection (h.p.i.), total cellular RNAs were extracted from the cells infected with WNV using TRIZOL reagent (Invitrogen), and the virion RNA was extracted from the culture supernatant of the virus-infected cells at 48 h.p.i. using TRIZOL LS reagent (Invitrogen). Northern blot analysis was performed as described previously (Narayanan et al., 2000) . To synthesize a WNV 5′-end probe, a 465-nt fragment corresponding to nucleotides 1 to 465 of WNV was reverse transcribed using a random hexamer as a primer at 42°C for 30 min using AMV-RT. The sequence of the indicated region was amplified by PCR using oligos #1 and #6 as primers ( Table 1 ). The reaction was carried out for 30 cycles of 94°C for 30 s for denaturation, 55°C for 30 s for annealing, and 72°C for 1 min for extension. To construct a 3′-end probe for the detection of the viral 3′-end RNA sequence, a 624-nt fragment of the terminal 3′-end sequence of WNV, corresponding to nucleotides 10,198 to 10,882, was prepared by digestion of the plasmid pCRBlunt-II WNV3′NCR, which contained the NS5 and 3′-noncoding region (NCR) of WNV, with restriction enzymes AatII and SacII. The DNA fragment for the 3′-end probe was separated on 1% TBE agarose gel and purified from the gel. The 5′-and the 3′-end fragments were labeled with DIG using a DIG-High Prime labeling Kit (Roche) according to the manufacturer's protocol. Viral RNAs were run on a formaldehyde-denatured 1% agarose gel, blotted onto nylon membranes, and hybridized with the DIGlabeled probes at 50°C overnight. DIG-labeled probes hybridized with viral RNA on the membrane were detected by a DIG-specific antibody according to the manufacturer's protocol.
RT-PCR for detection of viral RNAs
The WNV cDNAs were reverse-transcribed at 42°C for 30 min using AMV-RT from the viral specific RNAs, extracted from Vero E6 cells infected with WNV using TRIZOL reagent, as a template. We used 2 μg of total cellular RNA or 1 μg of virion-extracted RNA as templates for the RT reaction, and oligo #1 as the RT primer for viral negative-sense RNA, and oligo #2 as the primer for viral positive-sense RNA (Table 1) . To amplify the viral small RNAs containing the 5′-and the 3′-end sequences of viral genomic RNAs, we used oligos #1 and #2 as PCR primers and oligos #3 and #4 as nested PCR primers for the viral small RNAs ( Table 1 ). The reactions were performed for 30 cycles of 94°C for 30 s for denaturation, 55°C for 30 s for annealing, and 72°C for 1 min for extension. We examined the presence of viral negativesense small RNAs in WNV-NY-or JEV-JaGAr 01-infected cells. To detect the positive-or negative-sense small RNAs of WNV-NY, we used oligo #1 or #2, respectively, as the RT primer. For the detection of positive-or negative-sense small RNAs of JEV-JaGAr 01, we used oligo #7 or #8, respectively. Then, PCRs were performed using oligos #1 and #2 for WNV-NY or oligos #7 and #8 for JEV-JaGAr 01, respectively.
Construction of plasmids
To construct plasmids expressing an Aequorea coerulescens green fluorescent protein (AcGFP) flanked by the 5′-and the 3′-end sequences of WNV, corresponding to nucleotides 1 to 189 and 10,369 to 11,029, respectively (Fig. 3A) , we first amplified the 5′-and the 3′-end sequences of WNV using oligos #5 and #9, #10 and #11, respectively, as primer sets (Table 1) . Oligo #5 contained a SP6 RNA polymerase promoter sequence to drive in vitro RNA transcription by SP6 RNA polymerase. Each PCR product was inserted into the pCRBlunt-II vector (Invitrogen), and the sequences and direction in the plasmid were confirmed. We selected plasmids pCRB-5′WNV and pCRB-3′WNV, in which the 5′WNV and 3′WNV sequences were inserted in the sense and reverse direction, respectively, for further plasmid construction. pCRB-3′WNV was digested with restriction enzymes NotI and XbaI, and the fragment containing the 3′-end sequence of WNV was purified by column and inserted into the NotI/XbaI site of pCRB-5′WNV, referred to as pCRB-5′/3′WNV. The AcGFP sequence was amplified using pAcGFP1 (CLON-TECH) as a template, and oligos #12 and #13 as PCR primers (Table 1 ). The PCR fragment was digested with NotI and inserted into the NotI site of pCRB-5′/3′WNV. We then selected one clone in which the AcGFP sequence was inserted in the sense direction (referred to as pCRB-5′WNV/AcGFP/3′WNV). Using this plasmid, we synthesized a positive-sense RNA, composed of 5′-5′WNV/AcGFP/3′WNV-3′, by in vitro transcription. To construct a plasmid expressing a reverse-directed RNA of 5′WNV/ AcGFP/3′WNV, we amplified the entire sequence of 5′WNV/ AcGFP/3′WNV using pCRB-5′WNV/AcGFP/3′WNV as template and oligos #1 and #2 as primers. The PCR fragment was inserted into the pCRBlunt-II plasmid in the reverse direction and was referred to as pCRB-3′WNV/AcGFP/5′WNV.
In vitro transcription
Positive-and negative-sense RNAs, 5′-5′WNV/AcGFP/3′ WNV-3′ (+ RNA) and 5′-3′WNV/AcGFP/5′WNV-3′ (− RNA), were in vitro-transcribed using a mMESSAGEmMACHINE kit (Ambion). Briefly, pCRB-5′WNV/AcGFP/3′WNV and pCRB-3′WNV/AcGFP/5′WNV were digested with XbaI, treated with 1 unit of Mung bean nuclease (Promega) to produce blunt-end in the digested sites, and then supplied to in vitro transcription as templates. In vitro transcription was then performed according to the manufacturer's protocol.
Strand-specific RT-PCR
To examine the strand specificity of our strand-specific RT-PCR, 1 μg of in vitro-transcribed RNAs was mixed with Vero E6 cell lysate extracted with a phosphate buffer (pH 7.4) containing 1% Nonidet P-40 and 40 units of RNase inhibitor. The mixture was incubated on ice for 10 min, and then RNA was extracted from the mixture. cDNA was synthesized using oligos #1 and #2 as the RT primers for negative-and positivestrand RNAs, respectively ( Table 1 ). The PCR was performed as described above.
Preparation of RNA (Ribo-) probes
To make the sense-and antisense-Ribo-probes to detect viral negative-and positive-sense RNAs, respectively, we amplified the sequence of sRNA#7 cDNA using pCRB-II sRNA#7 as a template, and oligos #5 and #9 as the PCR primer set for constructing the sense-Ribo-probe, and oligos #14 and #15 for constructing the antisense-Ribo-probe. As oligos #5 and #14 contain SP6 RNA polymerase promoter sequences, we can drive the in vitro RNA synthesis using SP6 RNA polymerase. We used a DIG RNA Labeling Kit (T7 and SP6) (Roche) for in vitro transcription and labeling the RNA with DIG. The amounts of RNAs were estimated by measuring the band intensities on the membrane using a MultiGauge-Ver3.0-software system (FUJIFILM, Japan).
